Siemens Healthineers in Österreich verwendet Cookies um Statistiken über das Verhalten unserer Benutzer zu sammeln. Durch die Nutzung dieser Webseite erklären Sie sich mit der Verwendung von Cookies einverstanden. Detaillierte Informationen über den Einsatz von Cookies auf dieser Webseite erhalten Sie durch Klick auf „Cookie Richtlinien“. An dieser Stelle können Sie auch der Verwendung von Cookies widersprechen und die Browsereinstellungen entsprechend anpassen. Andernfalls nehmen wir an, dass Sie mit der Nutzung von Cookies einverstanden sind.
Siemens Clinical Laboratory (SCL) is an expert, CLIA-accredited clinical laboratory leading the way in innovative, high-complexity testing solutions to advance personalized medicine.
A wholly owned entity of Siemens Healthcare Diagnostics Inc. and based in Berkeley, California, SCL is uniquely positioned to provide high-complexity testing services for referring laboratory customers and innovative laboratory developed test (LDT) development to help pharmaceutical companies realize the potential of companion diagnostics. SCL has been certified under the Clinical Laboratory Improvement Amendments (CLIA) since 1994, accredited through the College of American Pathologists (CAP), and licensed in all U.S. states that require state-specific licensing. SCL has been a provider of accurate, reliable reference and back-up testing services for Siemens U.S. laboratory customers for over 18 years.
As an active participant in the California clinical laboratory community, SCL also provides:
Professional, continuing education to support relicensure requirements for Clinical Laboratory Scientists
Formal, California state-sponsored internship programs for the licensure of Clinical Genetic Molecular Biologist Scientists.
SCL has a growing track record of partnerships with pharmaceutical companies for companion diagnostics solutions, including ViiV Healthcare and Tocagen Inc. and continues to pursue leading-edge co-development opportunities.
“Our partnership with Siemens Healthcare Diagnostics is a valuable part of our commitment to addressing patient needs through developing innovative treatment approaches,” says Dr. John Pottage, Chief Scientific and Medical Officer, ViiV Healthcare. Dr. Harry E. Gruber, CEO of Tocagen Inc., agrees. “We believe that developing the necessary diagnostic tests with the right diagnostic partner is an important component for [our] successful commercialization.”
The products/features shown on this webpage are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.